Table 1.
In silico analysis of predicted BALB/c MHC class I epitopes.
| Antigenicity Score | Percentile Rank | Allele | Length | *Position | Peptide |
|---|---|---|---|---|---|
| Predicted Model 1 | |||||
| 0.400 | 0.4 | H-2-Dd | 9 | 15-23 | ISPRTLNAW |
| 0.658 | 0.4 | H-2-Dd | 9 | 32-40 | FSPEVIPMF |
| 1.763 | 0.4 | H-2-Dd | 9 | 363-371 | PGPGVRYPL |
| -0.099 | 0.5 | H-2-Kd | 9 | 142-150 | VRMYSPTSI |
| 0.450 | 0.6 | H-2-Kd | 9 | 233-241 | AYMGGKWSK |
| 0.228 | 0.7 | H-2-Kd | 9 | 7-15 | QGQMVHQAI |
| 0.324 | 0.7 | H-2-Dd | 9 | 83-91 | VHPVHAGPI |
| 1.880 | 0.7 | H-2-Dd | 9 | 222-230 | GGPGHKARV |
| 0.786 | 1 | H-2-Ld | 9 | 2-10 | IVQNIQGQM |
| -0.317 | 1 | H-2-Dd | 9 | 88-96 | AGPIAPGQM |
| Antigenicity Score | Percentile Rank | Allele | Length | *Position | Peptide |
| Predicted Model 5 | |||||
| -0.099 | 0.5 | H-2-Kd | 9 | 63-71 | VRMYSPTSI |
| 0.324 | 0.7 | H-2-Dd | 9 | 4-12 | VHPVHAGPI |
| 1.880 | 0.7 | H-2-Dd | 9 | 143-151 | GGPGHKARV |
| -0.317 | 1 | H-2-Dd | 9 | 9-17 | AGPIAPGQM |
| 1.763 | 0.4 | H-2-Dd | 9 | 165-173 | PGPGVRYPL |
| Predicted Model 6 | |||||
| 1.763 | 0.4 | H-2-Dd | 9 | 165-173 | PGPGVRYPL |
| -0.099 | 0.5 | H-2-Dd | 9 | 63-71 | VRMYSPTSI |
| 0.324 | 0.7 | H-2-Dd | 9 | 4-12 | VHPVHAGPI |
| 1.880 | 0.7 | H-2-Dd | 9 | 143-151 | GGPGHKARV |
| -0.317 | 1 | H-2-Dd | 9 | 9-17 | AGPIAPGQM |
BALB/c MHC I interacting with 9-mer peptides of predicted models were sorted based on percentile rank calculated by IEDB tools. Model 1: Full p24-AAY-Nef, Model 5: p24 (80-231)-AAY-Nef (70-90), Model 6: p24 (80-231)-AAY-Nef (120-150).
*Positions for peptides are as: Model 1:1-231 aa of p24, 232-234 aa of linker, 234-440 aa of Nef.
Model 5: 1-152 aa of p24, 153-155 aa of linker, 156-176 aa of Nef.
Model 6: 1-152 aa of p24, 153-155 aa of linker, 156-186 aa of Nef
Antigenicity scores ≥ 0.5 are shown in bold.